Medtronic SMall Annuli Randomized To Evolut or Sapien Trial (SMART Trial)

Brief description of study

The purpose of this study is to collect information and compare the safety and performance of self-expanding (SE) versus balloon-expandable (BE) transcatheter aortic valve replacement (TAVR) in patients with a small aortic valve.

Study participants will be randomized on a 1:1 basis to receive transcatheter aortic valve replacement (TAVR) with either a Medtronic SE or an Edwards BE TAV. Randomization will be stratified by site and gender

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions:
pacemaker,heart disease,cadiac resynchronization
Age: Between 18 Years - 99 Years
Gender: All

Updated on 09 Mar 2024. Study ID: 848494

You have contacted , on

Your message has been sent to the study team at ,

A copy of the message has been sent to your email

What happens next?

You can expect the study team to contact you via email or phone in the next few days.
Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).